ISPOR Fifth Annual European Congress Scientific Awards Winners
During the ISPOR Fifth Annual European Congress, 3-5 November 2002, De Doelen Congress Center, Rotterdam, The Netherlands, the scientific merit exhibited in contributed poster and podium presentations was recognized with awards given by authors' groups: general, new investigators and students. This year, the ISPOR Awards Committee evaluated approximately 48 podium presentations andover 326 poster presentations.
ISPOR Best Contributed Podium Presentation Award
BEST GENERAL PODIUM PRESENTATIONS
UT1 36 INTO 1 DOESN'T GO
Kind P, University of York, York, England
CV3 MULTI-COUNTRY COMPARISON OF HYPERTENSION COSTS FROM HOSPITALIZATIONS AND AMBULATORY CARE
Mullins CD1, Sikirica M1, Seneviratne V1, Ahn J1, Akhras KS2, 1University of Maryland, Baltimore, MD, USA; 2Pharmacia Corporation, Skokie, IL, USA
CC3 MEASURING POPULATION HEALTH FOR 191 COUNTRIES: WHO METHODS AND RESULTS
Mathers CD, Salomon J, Murray CJ, Tandon A, Sadana R, Ustun B, World Health Organization, Switzerland, Switzerland
BEST NEW INVESTIGATOR PODIUM PRESENTATIONS
WP3 WILLINGNESS TO PAY FOR A PHARMACIST INTERVENTION PROGRAM AMONG NON-COMPLIANT DYSLIPIDEMIA PATIENTS
Ali F, Laurin MY, Lariviere C, Tremblay D, Cloutier D, Pfizer Canada Inc, Kirkland,
QC, Canada
MD4 CHANGES IN COST-EFFECTIVENESS OVER TIME: THE CASE OF EPOETIN ALFA FOR RENAL REPLACEMENT THERAPY PATIENTS IN THE UK
Remak E1, Hutton J1, Zagari M2, 1MEDTAP International, London, UK; 2Ortho-Biotech, UK/Ireland, High Wycombe, United Kingdom
MD5 SHOULD THE EUROQOL DESCRIPTIVE SYSTEM BE EXTENDED FROM THREE TO FIVE LEVELS? A METHODOLOGICAL STRATEGY WITH AN EMPIRICAL PILOT
Janssen MF, Bonsel GJ, Academic Medical Centre, Amsterdam, Netherlands
BEST STUDENT PODIUM PRESENTATIONS
WP1 WILLINGNESS TO PAY FOR PHARMACIST-PROVIDED MENOPAUSE
AND HORMONE REPLACEMENT THERAPY CONSULTATIONS
Branvold AE, Barner J, Vincze G, University of Texas at Austin, Austin, TX, USA
WP2 ESTIMATING WILLINGNESS TO PAY FOR DRUGS TO TREAT ADHD. A CONTINGENT VALUATION STUDY IN STUDENTS
De Ridder A, De Graeve D, University of Antwerp, Antwerpen, Belgium
UT2 THE TRANSFORMATION OF SOCIAL PREFERENCE WEIGHTS : IMPLICATIONS
FOR COST-EFFECTIVENESS
Cleemput I1, Kind P2, Kesteloot K1, 1Catholic University Leuven, Leuven, Belgium; 2University of York, York, United Kingdom
ISPOR Best Contributed Poster Presentation Award
BEST GENERAL POSTER PRESENTATIONS
POD10 IMPROVEMENT IN QUALITY OF LIFE IN GROWTH HORMONE (GH) REPLACED HYPOPITUITARY ADULTS WITH GH DEFICIENCY IS CORRELATED WITH PATIENT-REPORTED OUTCOMES: ANALYSIS OF THE KIMS DATABASE
Koltowska - Häggström M1, Mattsson A2, Svensson J3, Johannsson G3, Rosen T4, 1KIGS/KIMS Outcomes Research, Stockholm, Sweden; 2KIGS/KIMS Outcomes Research, Pharmacia AB, Stockholm, Sweden; 3Research Centre for Endocrinology and Metabolism, Sahlgrenska University Hospital, Göteborg, Sweden; 4Sahlgrenska University Hospital, Gothenborg, Sweden
PHP13 INFLUENCING PRESCRIBING IN ENGLISH PRIMARY CARE: FINDINGS FROM THE MANMED SURVEY
Mason A1, Drummond M1, Towse A2, Cooke J3, 1University of York, York, United Kingdom; 2Office of Health Economics, London, United Kingdom; 3South Manchester University Hospitals NHS Trust, Manchester, United Kingdom
PHP28 ECONOMIC STUDY OF MALNUTRITION IN ELDERLY PATIENTS LIVING IN THE COMMUNITY : USE OF PROPENSITY SCORE TO ANALYZE OBSERVATIONAL DATA
Schmitt C1, Aussage P1, Arnaud-Battandier F2, 1MDS Pharma Services, Sevres, France; 2Nestlé Clinical Nutrition, Noisiel, France
BEST NEW INVESTIGATOR POSTER PRESENTATIONS
PNP5 DIRECT COSTS OF BACK PAIN IN THE UNITED STATES: A NATIONAL ESTIMATE
Mychaskiw MA, Thomas III J, Purdue University, West Lafayette, IN, USA
PCN2 COST-EFFECTIVENESS OF NEW CERVICAL CANCER SCREENING TECHNOLOGIES.
A GERMAN HEALTH TECHNOLOGY ASSESSMENT AND DECISION-ANALYSIS.
Sroczynski G1, Siebert U1, Voigt K2, Gibis B3, Aidelsburger P4, Wasem J4, Hillemanns P2, Engel J2, Hölzel D2, Goldie S1, 1Harvard School of Public Health, Boston, MA, USA; 2University Munich, Munich, Germany; 3National Association of Statutory Health Insurance Physicians, Berlin, Germany; 4University of Greifswald, Greifswald, Germany
PGS16 EVALUATION OF THE USE OF PROTON PUMP INHIBITORS IN A PUBLIC HOSPITAL IN HONG KONG
Lee VW1, Yick PK2, Yung G1, Tam KY1, 1The Chinese University of Hong Kong, Shatin, Hong Kong; 2Pamela Youde Nethersole Eastern Hospital, Hong Kong
BEST STUDENT POSTER PRESENTATIONS
PWM9 ASSOCIATION BETWEEN PATERNAL EXPOSURE TO SOLVENTS AND FETAL
MALFORMATIONS
de vries LE1, Logman JFS1, Hemels EH2, Khattak S3, Einarson T2, 1University of
Toronto, Toronto, ON, Canada; 2University of Toronto, Toronto, ON, Canada;
3Biopharmatrials Inc, Whitby, ON, Canada
PWM8 ASSOCIATION BETWEEN PATERNAL EXPOSURE TO SOLVENTS AND SPONTANEOUS ABORTIONS
Logman JFS1, de Vries LE1, Hemels M1, Khattak S2, Einarson T1, 1University of
Toronto, Toronto, ON, Canada; 2Biopharmatrials Inc, Whitby, ON, Canada
PIN21 HOSPITALISATION COSTS FOR YOUNG CHILDREN WITH RESPIRATORY
SYNCYTIAL VIRUS INFECTION
Vergouwe Y1, Polder JJ1, Rietveld E2, de Jonge EH1, Veeze HJ3, Moll HA2,
Steyerberg EW1, 1Erasmus Medical Center, Rotterdam, Netherlands; 2Erasmus
Medical Center-Sophia, Rotterdam, Netherlands; 3IJsselland Hospital, Capelle a/d
IJssel, Netherlands
A special thanks goes to all the judges, the
ISPOR Annual European Congress Awards Task Force Co-Chairs as well as the ISPOR
Awards Committee Chair who volunteered their time and efforts in selecting the
winners.
ISPOR AWARDS COMMITTEE CHAIR:
Newell McElwee PharmD, MSPH, Pfizer
ISPOR ANNUAL EUROPEAN CONGRESS AWARDS TASK FORCE CO-CHAIRS:
Jenifer Ehreth PhD - Medtronic Europe Sa (Poster)
Wolfgang Greiner PhD - University of Hannover (Podium)
ISPOR JUDGES:
Hiroshi Aino MS, Kobe University; Judith Baker PhD, CPA, Resource Group, Ltd;
Jamie Barner RPh, PhD, University of Texas at Austin; Stephen Beard MS, RTI
Health Solutions; Rami Ben-Joseph PhD, Pharmacia Corporation; Gilles Berdeaux
MD, Laboratoires Alcon France; Annabel Boler BSc, Heron Evidence Development;
Dale Christensen PhD, University of North Carolina; Peter Divinyi MD, Ministry
of Health, Medical Devices Authority; Pennifer Erickson PhD, O.L.G.A.; Joelle
Erkens PhD, PharmD, PHARMO Institute; DS Pete Fullerton PhD, University of
Washington; Isabelle Girod MSC, Mapi Values; Andreas Guhl MD, BIOGEN.S.A.; Dr.
Laszlo Gulacsi, Budapest University; Ali Haeri PhD, Pasteur Institute, Ministry
of Health & Medical Education; Klaus Hieke, NEOS Health AG; Daniel Huse MA,
Innovus Research Inc.; Lena Jacobson, Pfizer AB; Bas Janssen Msc, Academic
Medical Centre; K. Ian Johnson, Interphase; Gwendoline Kiebert PhD, Pfizer Inc;
Thomas Klose PhD, GlaxoSmithKline; Maria Koltowska MD, Pharmacia AB; Antoine
Lafuma, CEMKA-EVAL; Xavier Lenne, CRESGE; Eva Lydick PhD, AstraZeneca Inc;
Bradley Martin PharmD, PhD, University of Georgia; Susan Mathias MPH, Ovation
Research Group; Josephine Mauskopf PhD, MEDTAP International; Colleen Metge PhD,
University of Manitoba; Patrick Mollon MD, MBA, Pfizer Ltd; Helma Monteban,
Pfizer bv; Brenda Motheral RPh, PhD, Express Scripts; C. Daniel Mullins PhD,
University of Maryland; Marko A. Mychaskiw PhD, Purdue University; Christel
Naujoks MSc, Novartis Pharma GmbH; Niels Neymark MSc, EORTC; Beth O’Leary,
Quintiles; Jan Oostenbrink MSc, iMTA, Erasmus University Rotterdam; John E Paul
PhD, RTI Health Solutions; Pedro Plans-Rubio MD, MHA, MBA, Dept Sanitat;
Jonathan Plumb MS, AstraZeneca UK Ltd; Maarten Jacobus Postma PhD, Groningen
Univ Institute for Drug Exploration; Karen Rascati RPh, PhD, University of
Texas; Meir Raz MD, Maccabi Healthcare Services; Edit Remak, MEDTAP
International; Mason W. Russell, MAPE BIOGEN, Inc.; Maureen Rutten-van Mölken
PhD, iMTA, Erasmus University; Stephen Ryan MD, MA, University of Kentucky; Dr.
Eugene Salole, Johnson & Johnson Medical; Elly A. Stolk MSc, Institute for
Medical Technology Assessment; Marco Tangelder MD, PhD, Pharmacia; Betina
Thordal Blak MSc, University of Maryland; Marianne van Genugten, National
Institute of Public Health & the Environment; Henri Vanden Baviere MD, BIGE-IBES;
Birgitta von Scheele MS, RTI-Health Solutions; Robert Welte MSc, MPH, University
of Ulm; Kathleen A. Weis PhD, Pfizer, Inc; Richard Willke PhD, Pharmacia; Jerome
Wilson PhD, Pfizer Pharmaceuticals; Rochelle Yalkowsky, University of Arizona
|
Jennifer Ehreth PhD and Newell McElwee PharmD, MSPH pictured below presenting the Scientific Awards |
|||
 |
 |
||
|
Poster Award winner: Mike Drummond |
Contributed Poster Award
winner: |
||
 |
 |
||
|
Contributed Paper Award
winner: |
Contributed Paper Award winner: Laurens de Vries |
||
